skip to primary navigationskip to content

Cambridge Institute for Medical Research

Department A-Z

Our strategy

We aim to create an inspiring environment in which outstanding scientists can excel. By providing state-of-the-art core facilities and support for our researchers, we foster new collaborations that spark discoveries about fundamental cellular processes and their relevance in disease.

Read more

Research advances

In Traffic, the Deane lab have revealed a new cell biological framework for pathogenesis of the fatal neurodegenerative disorder Krabbe Disease, by characterizing a series of disease mutations in the lysosomal enzyme galactocerebrosidase (GALC).

Read more

FEBS National Lecture Award

Alan Warren will receive a FEBS National Lecture Award at the Austrian Society for Molecular Biology and Biotechnology annual meeting in September. These awards, established to commemorate the 40th anniversary of FEBS, recognize the achievements of distinguished scientists.

Read more

Thudichum Medal award

Congratulations to David Rubinsztein, whose award from the Biochemical Society recognizes his outstanding contributions to the field of neuroscience.

Read more


A unique partnership between basic and clinical research, aiming to understand the cellular basis of disease






New publications

 

Deane lab (Traffic 2016)

Uncovering Krabbe Disease pathogenesis.

 

Smith lab (PLoS Genet. 2016)

eQTL mapping of immune disease.

 

Maxwell lab (Sci. Rep. 2016)

Targeting hypoxic cancer cells.

 

Reid lab (PloS One 2016)

Detecting motor defects in spastin mutants.

 

Rubinsztein lab (Nature Comm. 2016)

Autophagy control in stem cells.

 

Ron lab (eLife 2016)

AMPylation of BiP ER chaperone.